Padma Mahant, MD, joined CND Life Sciences in May 2023 as Director of Medical Affairs, a role that allows her to utilize her clinical, education and research experience in serving as a physician ambassador for CND and its diagnostic offerings. “I field inquiries from and conduct pathology report consultations with neurologists, geriatricians, internists, advanced practice providers (APPs), and other healthcare professionals regarding the potential use, benefits, and features of the Syn-One Test®.”
In addition, Dr. Mahant develops medical educational programs for patients and clinicians, supports and builds relationships with investigators interested in research utilizing the Syn-One Test, and develops relationships with patient advocacy organizations.
Dr. Mahant brings more than 20 years of experience as a movement disorder specialist to CND, in both academic and private practice and settings, including Barrow Neurological Institute, the University of Arizona, and Foothills Neurology, all located in Arizona.
“In addition to developing long-term supportive relationships with my patients and their caregivers, with a focus on the latest strategies for improving quality of life, I have participated in varied research projects over my career,” with an interest in multiple facets of Parkinson’s disease, including motor control, gait, deep brain stimulation, and pharmaceutical trials.
Highlights for Dr. Mahant in terms of her career have included leading team-based multidisciplinary therapy programs for patients with Parkinson’s and helping to educate and support patients, medical students, and fellow clinicians. “It has been my honor to participate in programs championed by multiple movers and shakers in the Parkinson’s field,” including pharmaceutical and device industry experts, patients, caregivers-turned-advocates, and activists including Muhammad Ali, Janet Reno, Brian Grant, Davis Phinney, and Michael J. Fox, “… all personal heroes to me and to so many patients living with Parkinson’s and related conditions.”
When Dr. Mahant learned about CND, it was clear to her that “the expertise, integrity, and compassion of the founders, Drs. Todd Levine, Christopher Gibbons, and Roy Freeman, have been carried over as key components of the ethos of CND.”
Dr. Mahant describes the culture at CND as innovative and supportive, and describes her colleagues as “accomplished, kind, and generous with their time and knowledge.”
At CND, Dr. Mahant has been able to incorporate her skills, knowledge, and compassion in a way that she hopes will further enhance and magnify her impact in her chosen field. “It has been a tremendous honor for me to assist and support patients and clinicians in the rapidly advancing field of diagnostics in Parkinson’s and related conditions.” She is confident that CND will increasingly be a part of the solution for diagnosing neurodegenerative conditions at its earliest stages, “…allowing CND to be a key partner in the eventual development of strategies that might delay or even halt the progression of these neurodegenerative conditions.” For Dr. Mahant, and for so many others that she has had the pleasure of working with throughout her career, this would be a dream come true.
